More States Eye Drug Affordability Boards, PBM Regulations

Some states are adding more ‘muscular attributes’ to their Rx boards, such as setting upper limits based on the pending Medicare prices, but federal ERISA legislation still limits the boards’ impact.

50 states of pills
States are still in the early stages of implementing their drug pricing boards. • Source: Shutterstock

PBM and drug pricing regulation will continue to be hot topics at the state level after several years of busy lawmaking, experts predict, even as PBM reforms appear stalled in Congress. They predict that more states than ever will continue to embrace or pursue policies like drug affordability review boards.

Key Takeaways

  • Over 100 drug pricing bills are under consideration in 29 states, much of it based on NASHP model legislation.

“I do think the momentum is still strong, because states have the ability to do a lot more,” Kate Sikora,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access